Long Noncoding RNA TUG1 Inhibits Tumor Progression through Regulating Siglec-15-Related Anti-Immune Activity in Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death, and its biology remains poorly understood, especially in regards to the immunosuppression induced by immune checkpoints, such as Siglec-15. Most cancer treatments composed of immune checkpoint inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yanyi, Lyu, Jiayi, Guo, Yaoguang, Yao, Yuan, Hu, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885264/
https://www.ncbi.nlm.nih.gov/pubmed/35237695
http://dx.doi.org/10.1155/2022/9557859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885264/
https://www.ncbi.nlm.nih.gov/pubmed/35237695
http://dx.doi.org/10.1155/2022/9557859

Ejemplares similares